In 2022, President Biden re-ignited the Cancer Moonshot with a call to cut the cancer death rate by half and “improve the experience of people and families living with and surviving cancer.” Both goals are ambitious…
Continue Reading
Lupin Digital Health introduces Lyfe, an advanced e-clinic for heart failure patients in India, managed by a team of medical professionals and equipped with AI-powered tools and globally approved medical devices. The virtual clinic…
Continue Reading
The digital health arm of India-based pharmaceutical company Lupin has unveiled its e-clinic attending to heart failure patients.Called Lyfe, the virtual clinic is manned by a team of paramedics, nurses, cardiotherapists, health coaches and…
Continue Reading
What You Should Know: Today, Santa Cruz-based Capstan Medical, a developer of minimally invasive technology to address heart valve disease, announced $31.4M Series B investment round led by Eclipse.The Series B round included participation…
Continue Reading
We like to regularly feature a healthcare IT job that might be of interest to readers. Today, we’re featuring the Simulation Operations Specialist at Natividad position that was recently posted on Healthcare IT Central….
Continue Reading
The imperative to enhance access to quality care and research is a central concern gripping both the healthcare and pharmaceutical sectors. At the heart of this challenge lies the crucial necessity for clean and…
Continue Reading
Data analytics company Qureight has entered into a multi-year strategic research collaboration with AstraZeneca that will use AI models to accelerate research into lung diseases.Through the agreement, AstraZeneca will use Qureight’s proprietary analytics platform…
Continue Reading
It’s well known that heart failure is a sweeping national problem — the condition affects more than 6 million Americans and costs the country more than $30 billion per year.
Geisinger, like many other health…
About one in every four male deaths is related to heart disease, making it the leading cause of death for men in the U.S. One company is looking to alleviate the situation.
San Francisco-based Hims…
Machine learning-based algorithms can now be used to help detect atrial fibrillation, asymptomatic left ventricular systolic dysfunction, and cardiac amyloidosis. Even more digital diagnostic tools are on the drawing board.
By John Halamka, M.D., President,…
Continue Reading
